Portfolio Design Labs’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Portfolio Design Labs's BMY Position: Q1 2026 in Review
Portfolio Design Labs increased its Bristol-Myers Squibb (BMY) stake by 49% in Q1 2026, buying an estimated $235K and bringing the position to 12,242 shares worth $742K. The position accounts for 0.13% of the portfolio, ranked #151.
Portfolio Design Labs first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.08M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Portfolio Design Labs held 12,242 shares of Bristol-Myers Squibb worth $742K as of Q1 2026.
- Portfolio Design Labs bought 4,027 Bristol-Myers Squibb shares in Q1 2026, an estimated $235K.
- Bristol-Myers Squibb made up 0.13% of Portfolio Design Labs's portfolio in Q1 2026, its #151 holding.
- Portfolio Design Labs first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
- Portfolio Design Labs's Bristol-Myers Squibb position peaked at $3.08M in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Portfolio Design Labs's 13F filing for Q1 2026, filed 11 May 2026.